Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience

Table 1 Clinicopathologic characteristics of 14 patients with attempted cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion n (%)

Age (yr), median (range)	64 (43-77)
Female gender	7 (50)
Preoperative imaging
Computerized tomography	14 (100)
Positron emission tomography	5 (36)
Type of cancer
Appendiceal	5 (36)
Colonic	4 (29)
Mesothelioma	2 (14)
Gastric	1 (7)
GIST	1 (7)
Unknown	1 (7)
Successful CRS and HIPEC	11 (79)
Curative intent CRS and HIPEC	8 (57)
PCI for curative CRS/HIPEC, median (range)	5 (3-26)
CCR for curative CRS/HIPEC, median (range)	0 (0-1)

GIST: Gastrointestinal stromal tumor; PCI: Peritoneal carcinomatosis index; CCR: Completeness of cytoreduction score; CRS: Cytoreductive surgery; HIPEC: Hyperthermic intraperitoneal chemoperfusion.

Table 2 Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion organ resections according to tumor type

CRS and HIPEC procedures (n = 11)	Colon (n = 2)	Appendix (n = 4)	Mesothelioma (n = 2)	Gastric (n = 1)	Other1 (n = 2)
Gastrectomy	0	1	0	1	0
Total		0		1
Wedge		1		0
Colectomy	2	4	0	1	0
Total colectomy	0	1		0
Right hemicolectomy	1	2		0
Left hemicolectomy	0	0		1
Sigmoidectomy/LAR	1	1
Small bowel resection	1	0	0	2	0
Salpingo-oophorectomy	1	1	0	0	0
Pancreatectomy (distal)	0	1	0	0	0
Splenectomy	1	1	1	1	0
Cholecystectomy	2	2	1	1	0
Liver resection	1	1	0	0	0
Left lateral segmentectomy	1	0
Wedge resection	0	1
Palliative procedures (n = 3)
Laparoscopic HIPEC	0	0	0	0	2
Limited debulking and HIPEC	0	1	0	0	0

¹Gastrointestinal stromal tumor (n = 1) and adenocarcinoma of unknown origin (n = 1).

CRS: Cytoreductive surgery; HIPEC: Hyperthermic intraperitoneal chemoperfusion.

Table 3 Postoperative course in 11 patients who underwent cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion

Complication	n (%)
30-d mortality	0
30-d morbidity	4 (36)
Ileus grade 3	3 (27)
Hypertension grade 3	1 (9)
In-hospital stay (d), median (range)	9 (5-18)